Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Clinical and Medico-economic Impact of SinnoTest®, a Software That Predicts the Effectiveness of Biotherapy Treatments, in Patients With Rheumatoid Arthritis (RA)

NCT04117165 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.

NCT NCT04117165
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04117165 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Clinical and Medico-economic Impact of SinnoTest®, a Software That Predicts the Effectiveness of Biotherapy Treatments, in Patients With Rheumatoid Arthritis (RA)
Lead sponsor
University Hospital, Grenoble
Phase
Not applicable
Overall status
Withdrawn
Start date
March 1, 2021
Completion date
September 1, 2023
Enrollment
0 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis, rheumatoid, biological therapy